Blog
About

  • Record: found
  • Abstract: found
  • Article: found
Is Open Access

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087

, 1 , 2 , 3 , 4 , 5 , 6 , 6 , 6 , 7 , 2 , 8

Journal for Immunotherapy of Cancer

BioMed Central

30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015)

4-8 November 2015

Read this article at

Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Related collections

      Author and article information

      Affiliations
      [1 ]City of Hope Medical Center, Duarte, CA, USA
      [2 ]Dana-Farber Cancer Institute, Boston, MA, USA
      [3 ]The University of Texas MD Anderson Cancer Center, Houston, TX, USA
      [4 ]Gustave Roussy Cancer Campus, Villejuif, France
      [5 ]University of Bologna, Bologna, Italy
      [6 ]Merck & Co., Inc., Kenilworth, NJ, USA
      [7 ]Uppsala University, Uppsala, Sweden
      [8 ]Memorial Sloan Kettering Cancer Center, New York, NY, USA
      Conference
      J Immunother Cancer
      J Immunother Cancer
      Journal for Immunotherapy of Cancer
      BioMed Central
      2051-1426
      2015
      4 November 2015
      : 3
      : Suppl 2
      : P146
      4645991 2051-1426-3-S2-P146 10.1186/2051-1426-3-S2-P146
      Copyright © 2015 Chen et al.

      This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

      30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015)
      National Harbor, MD, USA
      4-8 November 2015
      Categories
      Poster Presentation

      Comments

      Comment on this article